Key facts
- It has raised $410K; the latest was Early Stage VC ($410K) in Oct 2025.
- Notable investors include Innovatiefonds Noord-Holland, University of Amsterdam, Amsterdam Academic Ventures, Innovation Exchange Amsterdam.
- Status: Privately Held (backing).
- ·The complete investor list — 4 names
- ·Watchlist + deal alerts for InspectT
- ·The full record, as it builds
Funding rounds
No funding rounds for InspectT are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About InspectT
Developer of infrared-compatible microfluidic devices designed for molecular and nanoparticle sizing using optical spectroscopy. The company's platform integrates with standard infrared spectrometers, featuring a micron-scale spacer compatible with heavy water, and has been validated on diverse molecules, enabling researchers in molecular sciences to perform non-invasive, precise measurements of size and structure.
- Sector
- Healthcare
- HQ
- Amsterdam, Netherlands
- Founded
- 2024
- Website
- inspectt.nl/
- Ownership
- Privately Held (backing)
InspectT doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in InspectT shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on InspectT in its N-PORT filings yet. We sweep new filings monthly.